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INTRODUCTION
Nausea and vomiting are common symptoms in
pregnancy. Incidence rate reached 70% in preg-
nant women and a quarter of the women com-
plained that they were unable to work because of
complaints of nausea, vomiting.1
Pharmacological interventions have proven ef-
fective in reducing complaints of nausea and vom-
iting in pregnant women. But because almost all
women feel the complaint most severe during the
first trimester of pregnancy, while embryogenesis
happened, there were fear that the drugs interfer-
encing the health of the fetus. In addition, most
drugs to deal with complaints of nausea and vom-
iting side effects makes drowsiness. Drowsiness
was also one of the side effect of anti emetic drugs
which can be a burden for working pregnant wo-
men.2
Therefore, an alternative therapy is needed to
deal with the complaints of nausea and vomiting
in pregnancy. Noninvasive electrical stimulation
Abstract
Objective: To determine the benefit of electroacustimulation in re-
ducing nausea and vomiting in the first trimester of pregnancy.
Methods: This study is an experimental study. The subject were 40
pregnant women divided into 2 groups randomly. The control group
was given vitamin B6 3x30 mg per day and the case given the elec-
troacustimulation device. The degree of severity of nausea and vom-
iting of patients assessed before and 3 days after treatment using
Pregnancy Unique Quantification of Emesis and Nausea (PUQE)
questionnaire.
Result: There were no differences between groups in gestational
age at entry and PUQE score pre-treatment. After 3 days therapy,
there were significant decrease in PUQE score in group receiving B6
(p=0.004) and also in electroacustimulation group (p=0.000). How-
ever, the change in PUQE score was not significantly different bet-
ween the two groups (p=0.286).
Conclusion: From the results of this study concluded that elec-
troacustimulation is effective for reducing nausea and vomiting in
the first trimester of pregnancy. There is no difference in effective-
ness between electroacustimulation and vitamin B6 to treat nausea
and vomiting in the first trimester of pregnancy.
[Indones J Obstet Gynecol 2013; 37-2: 71-6]
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Abstrak
Tujuan: Untuk mengetahui manfaat elektroakustimulasi dalam me-
ngatasi keluhan mual dan muntah pada trimester pertama kehamil-
an.
Metode: Merupakan uji eksperimental yang diikuti oleh 40 ibu hamil
yang dibagi ke dalam 2 kelompok secara acak. Kelompok kontrol
diberikan vitamin B6 3x30 mg per hari dan kelompok kasus diberikan
alat elektroakustimulasi. Derajat keparahan mual dan muntah pasien
dinilai pra dan 3 hari pasca perlakuan dengan menggunakan kuesio-
ner Pregnancy Unique Quantification of Emesis and Nausea (PUQE).
Hasil: Tidak didapatkan adanya perbedaan usia kehamilan dan skor
PUQE pra perlakuan pada kedua kelompok. 3 hari pasca perlakuan di-
dapatkan pengurangan skor PUQE yang bermakna secara statistik
baik pada kelompok vitamin B6 (p=0,004) maupun pada kelompok
elektroakustimulasi (p=0,000). Namun, perubahan skor PUQE pada
kedua kelompok tersebut tidak berbeda bermakna scara statistik
(p= 0,286).
Kesimpulan: Didapatkan kesimpulan bahwa elektroakustimulasi
efektif untuk mengatasi mual dan muntah pada trimester pertama ke-
hamilan. Tidak terdapat perbedaan efektivitas antara elektroakusti-
mulasi dan vitamin B6 dalam mengatasi mual dan muntah pada tri-
mester pertama kehamilan.
[Maj Obstet Ginekol Indones 2013; 37-2: 71-6]
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atau titik neiguan, pregnancy unique quantification of emesis and
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(electroacustimulation) median nerve at the P6
point can be an alternative therapy to deal with
complaints of nausea and vomiting caused by mo-
tion sickness, chemotherapy, anesthesia, and preg-
nancy.3
This study is aimed to know the benefits elec-
troacustimulation in reducing nausea and vomiting
in the first trimester of pregnancy.
METHOD
The study was an experimental study. The research
was conducted at the obstetrics clinic of the Dr.
Cipto Mangunkusumo General Hospital, Rahiem
Maternity Clinic, and Bunda Aliyah Women and
Children’s Hospital in patients who experienced
emesis gravidarum. The study was conducted from
July 2012 to September 2012.
Nerve stimulation therapy done by using Re-
letexTM model that has been approved by the U.S
Food and Drug Administration (FDA). 
The inclusion criteria were pregnant women
with emesis gravidarum below 16 weeks of gesta-
tion who were willing to follow this study. The ex-
lusion criteria were patient having other conditions
that have similar symptoms or using a pacemaker
or had previously used acupuncture.
To calculate of the sample size, we use formula
of statistical software EPICALC 2000, which defines
a total sample size was 20 respondents fatherly
each group.
Patients who have been selected according to in-
clusion and exclusion criteria were given informed
consent of the research to be conducted. Once it is
done random sampling, the first group will receive
treatment stimulation while the second group will
get a tablet of vitamin B6. Respondents will receive
treatment for 3x24 hours. During the study patient
fills PUQE scoring system to assess complaints of
nausea and vomiting respondents efore and 3-days
after treatment. Respondents are entitled to with-
draw from the study when she felt worsening
symptoms of nausea and vomiting during treat-
ment and respondents remain included in the data
analysis. Respondents also asked to wrote per-
ceived side effects when getting treatment. All data
from the study sample are recorded on a form of
research. Then do the tabulation of data and then
the data were statistically processed using SPSS
17.0
RESULT
Of the 40 samples obtained, 18 samples obtained
from RSCM, 10 samples obtained from RB Rahiem,
and 12 samples of RSIA Bunda Aliyah. Sampling
was done by random sampling. Of the 40 patients,
20 patients were included in the control group (vi-
tamin B6 therapy) and 20 patients included in the
treatment group (electroacustimulation).
Age of subjects ranged from 19 to 37 years with
a mean age of 26 years. Subject gestational age
ranged from 6 to 15 weeks with a mean gestational
age of 9 weeks. Of the 40 subjects studied, 15 pa-
tients is primigravida and 25 patients is multi-
gravida.
Shapiro-Wilk normality test shows the data dis-
tribution is not normal in both groups (p<0.05).
Data distribution is not normal in this study due to
the small sample size. Further analysis using the
median, minimum and maximum values of the two
groups.
Table 1. Characteristics of Study Subjects.
Variable (n = 40)
Age (years)
• Max 37
• Median 27
• Min 19
Gestational Age (weeks)
• Max 15
• Median    9.5
• Min  6
Parity
• Primigravid 15
• Multigravid 25
Based on the Mann-Whitney test, found no sta-
tistically significant difference in PUQE total score
between the vitamin B6 and electroacustimulation
groups before treatment. So it can be concluded
there is no significant difference in the severity of
nausea and vomiting between the two groups be-
fore treatment.
Most pregnant women in the control group suf-
fered from moderate degree of nausea and vomit-
ing before treatment (n = 16). Only one person suf-
fering severe degree from nausea and vomiting. On
the 3rd day of treatment, there is a decrease in the
number of pregnant women who suffer from mo-
Indones J
72  Pamungkas and Prasmusinto Obstet Gynecol
|
derate degree of nausea and vomiting from 16 peo-
ple to just 10 people. However, we note that actu-
ally one pregnant women experience worsening of
nausea and vomiting after administration of vita-
min B6 therapy.
Based on Wilcoxon test, there is a significant dif-
ference (p<0.05) before and after therapy with vi-
tamin B6.
In the treatment group, there is a decrease in
the number of pregnant women with moderate de-
gree nausea and vomiting from 19 to only 8 people.
There were no patients with severe degrees of nau-
sea and vomiting in this group.
Table 2. PUQE Score on Case Group (Electroacustimulation).
n ≤6 7-12 ≥13 p*
PUQE score pre-treatment 20  1 19 0 0.00
PUQE score after 3-days
treatment
20 12  8 0 0
* Wilcoxon test
Based on Wilcoxon test, there is a significant
difference in the degree of nausea and vomiting
before and after electroacustimulation therapy
(p<0.05).
In this study, we also tried to compare the effec-
tiveness of vitamin B6 with electroacustimulation
by taking into account the change in total score
PUQE before and after treatment in both groups of
patients.
Based on the Mann-Whitney test, the results ob-
tained were not statistically significant (p>0.05). It
can be concluded that there were no difference in
effectivity between vitamin B6 and electroacusti-
mulation to treat nausea and vomiting in preg-
nancy.
Table 3. PUQE Score on Both Group.
-3 – 0 1 – 3 4 – 6 p*
Vitamin B6 5 13 2 0.286
Electroacustimulation 4 10 6
*Pearson Chi-Square
DISCUSSION
This study is the first study in Indonesia which try
to figure out the effect of electroacustimulation in
reducing complaints of nausea and vomiting in the
first trimester of pregnancy. In this study electro-
acustimulation prove useful in overcoming nausea
and vomiting in the first trimester of pregnancy.
Electroacustimulation is as effective as vitamin B6
in dealing with nausea and vomiting in the first tri-
mester of pregnancy. Almost all patients experi-
ence improvement of symptoms and signs of nau-
sea and vomiting during the treatment period.
Nausea and vomiting is both a complain that is
often felt in the first trimester of pregnancy. Most
of the patients complained of mild to moderate
symptoms, only 1% who experienced hyperemesis
gravidarum.1,4 Exact etiology is unknown to date.
Increased chemical substances due to pregnancy,
such as hormone chorionic gonadotropin (hCG) is
estimated to have a role in the pathogenesis of
emesis gravidarum. Increased progesterone is also
thought to cause symptoms of nausea and vomiting
through the mechanism of gastroesophageal
sphincter relaxation.5,6 Social and psychological
factors also play a role in the symptoms.7
There have been many studies that examine
both pharmacological and non-pharmacological
management of nausea and vomiting in pregnancy.
Vitamin B6 is the first-line drug for nausea and
vomiting in pregnancy which has been proven to
be effective and safe when used according the rec-
ommended dosage.8
Sahakian9 conducts research in 59 pregnant wo-
men with complaints of nausea and vomiting. A to-
tal of 31 patients were asked to consume vitamin
B6 3 x 25 mg orally and 28 patients taking placebo
in the manner and dosage forms of the same. Pa-
tients were then followed for 72 hours. At the end
of the observation period, only 8 of the 31 patients
in the vitamin B6 group who experienced vomiting
compared with 15 of 28 patients in the placebo
group (p<0.05). In these studies proved that the
consumption of vitamin B6 25 mg per 8 hours is
more effective than placebo in mild to moderate
nausea and vomiting of pregnancy, but not to the
severe nausea and vomiting (hyperemesis gravi-
darum).
Research with a similar result was also done by
Vutyavanich.10 A total of 342 pregnant women
with gestational age less than 17 weeks partici-
pated in this study. Patients were divided into 2
groups, vitamin B6 and placebo by double-blind
random sampling. Patients were followed for 5
days. The severity of nausea measured using VAS
(Visual Analogue Scale) and frequency of vomiting
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calculated for 24 hours before and after 5 days of
treatment. The result is nausea in the vitamin B6
significantly reduced compared to the placebo
group. Although the average number of vomiting
was decreased in the vitamin B6 group, but the sta-
tistic test is somehow show not significant result.
The conclusion that can be drawn from this study
is vitamin B6 is effective to reduce complaints of
nausea in early pregnancy.
Although many studies have suggested the effi-
cacy of vitamin B6 for nausea and vomiting in preg-
nancy, but the mechanism of action of vitamin B6
to treat nausea and vomiting in pregnancy has not
yet been clearly established. A new note is vitamin
B6 plays an important role in the homeostasis of
the body because it is water soluble and its role as
a coenzyme in the metabolism of fats, carbohy-
drates, and amino acids. Previous studies have
noted that vitamin B6 may reduce mild to moder-
ate nausea, but not vomiting complaints. In addi-
tion, in a study by Magee’s8, vitamin B6 proven to
be safer than other antiemetic drugs. Therefore, vi-
tamin B6 can be recommended as first-line treat-
ment for patients with mild-moderate nausea and
vomiting, but not for patients with hyperemesis
gravidarum.
Electroacustimulation is a noninvasive proce-
dure that allegedly effective way to overcome or
reduce nausea and vomiting in pregnancy. This
tool can also be used as an alternative therapy for
some patients who have a fear of its own to take
medicine. Electroacustimulation so far have not
proven to give adverse effects on pregnancy. Re-
cent research shows that acustimulation not asso-
ciated with increased perinatal morbidity and mor-
tality.11,12
Basically, electroacustimulation working mecha-
nism is as the same as regular acupressure used to
stimulate acupuncture point P6 (Neiguan). Disad-
vantages of regular acupressure tools is they are
often not correctly stimulate P6 point. In electro-
acustimulation, stimulation of the P6 point is done
by an electric wave. When the point of stimulation
is right, it will give the sensation of tickling down
to the fingertips. The sensation is not found in or-
dinary acupressure tool. While electroacusti-mula-
tion advantages compared with acustimulation is
on the adjustable intensity of the impulse in elec-
troacustimulation.
Currently not many electroacustimulation tools
available on the market. In our study, ReletexTM
selected as the tool because it is easy to use and
the intensity of the electrical stimulation can be ad-
justed according to the patient’s needs.
In this research we divided subjects into 2
groups, the control group and the case group. Our
control group asked to take vitamin B6 3 x 30 mg
for 3 consecutive days, in accordance with the rec-
ommended dosage. As for the case group, we ask
the patient to use the electroacustimulation device
all day for 3 consecutive days. Patients simply re-
move the electroacustimulation device when she
was about to shower or do an activity that will
come into contact with liquid.
Our sampling was done by random sampling so
that there is no difference between the two groups.
Evidently the two groups in this study remained
statistically equivalent reflected in the similarity
degree of nausea and vomiting in both groups be-
fore treatment.
We followed our patients for 3 days. During that
time we found the symptoms of nausea and vom-
iting was significantly reduced in both groups. In
our study none of the patients complained of side
effects or discomfort when using the tool elec-
troacustimulation. Our results prove that electro-
acustimulation is effective to treat nausea and
vomiting in the first trimester of pregnancy. This
study is also consistent with other studies that
mention the positive effects of acustimulation and
acupressure to treat nausea and vomiting in preg-
nancy. In the review study by Roscoe and Mat-
teson13, carrying approximately 12 publications
that examine the effects of acupressure and acu-
stimulation in overcoming nausea and vomiting in
pregnancy. With different research methodology
and different ways of working, a study conducted
by Hyde, De Aloysio, Evans, Wagner, O’Brien,
Miller, and Norheim reached the same conclusion
that the stimulation of the P6 point (Neiguan) may
reduce nausea-vomiting in pregnancy. No harmful
effects were reported with this treatment method.
From all of the reviewed publications, only the
study by Evans14 comparing the effectiveness elec-
troacustimulation with placebo. As a result, 87%
(20 of 23) of pregnant women experience nausea
and vomiting reduced after they used electroacu-
stimulation, compared with only 43% (10 of 23)
pregnant after using the placebo.
The most important part of this research is how
to make objective of the subjective symptoms of
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nausea and vomiting experienced by patients. Pre-
vious gold standard questionnaire to assess the se-
verity of nausea and vomiting is one of Rhodes In-
dex. PUQE (Pregnancy-Unique Quantification of
Emesis and Nausea) is a new questionnaire, which
is a modification of the Rhodes index. PUQE is more
simple and has been proven to be able to assess
the degree of severity of nausea and vomiting in
pregnancy as accurately as Rhodes Index, as pro-
posed by Koren.15
Nausea and vomiting in pregnancy in general
will be reduced until it disappears at 14-16 weeks
of gestation so that it can be a confounding factor
in this study. In our study, the mean gestational
age at the commencement of the research is still
relatively early (group = 9:35 ± 2:18 electroacu-
stimulation weeks; groups of vitamin B6 = 9.20 ±
1852 weeks), so confounding factor can be elimi-
nated.
There is a study with a similar protocol to our
study, which tried to compare the effectiveness of
vitamin B6 with acustimulation to treat nausea and
vomiting in pregnancy. The study was conducted
by Jamigorn and Phupong16 in 2005 in Bangkok,
Thailand. They divided 60 patients into two
groups, the group of vitamins B6 and acustimula-
tion group. In the vitamin B6 group, patients were
asked to consume vitamin B6 for 2 x 50 mg and
using electroacustimulation at a point more lateral
than P6 (the radius). In contrast, in the group
acustimulation, patients were asked to use the
right tool and continuously during the study at the
P6 point and were asked to consume a placebo tab-
let which shape, size, and manner of administration
is similar with vitamin B6. Patients were also asked
to fill Rhodes Index for 5 days of research time.
That study reveal the same result with our study.
Both vitamin B6 and electroacustimulation may re-
duce nausea and vomiting in pregnancy. However,
there was no difference in effectiveness between
electroacustimulation with vitamin B6 to treat mild
to moderate nausea and vomiting in the first tri-
mester of pregnancy.
Our research goal is to examine the effectiveness
of new treatment methods to deal with complaints
of nausea and vomiting in pregnancy. To that end,
we compare it to commonly used drugs and has
proven efficacy and safety for the treatment of
emesis gravidarum, which is vitamin B6. This study
did not escape the limitations. However, small re-
search subjects does not make the results of this
study become invalid. Based on previous studies
that have been done with number of subjects that
are similar also come to the conclusion that the P6
point stimulation has benefits for nausea and vom-
iting in pregnancy. Gestational age, educational le-
vel, occupation, and number of parity did not we
take into account in the statistical analysis as fac-
tors affecting nausea and vomiting in pregnancy
because it is not in accordance with the literature.
The most ideal study protocol is to use a placebo
in both groups of subjects, as is done by Jamigorn
and Phupong16. However, due to limitations of time
and research tools such protocol we can not do.
Although there are limitations to this study and
the exact mechanisms electroacustimulation to
treat nausea and vomiting are still uncertain, this
tool has advantages in terms of ease of use and no
side effects have been proven to date. Therefore,
electroacustimulation can be recommended to be
given to pregnant women with nausea and vomit-
ing in the first trimester of pregnancy.
CONCLUSION
Electroacustimulation is effective for nausea and
vomiting in the first trimester of pregnancy. There
is no difference in effectiveness between electro-
acustimulation and vitamin B6 to treat nausea and
vomiting in the first trimester of pregnancy. So,
electroacustimulation can be used as an alternative
therapy to treat nausea and vomiting in the first
trimester of pregnancy.
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